FDA Inspection 788281 — Wacker Biotech B.V.
The FDA completed an inspection of Wacker Biotech B.V. on June 7, 2012 in Amsterdam. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- June 7, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Amsterdam (Netherlands)